| Dr Shanon M Tuter-spitzley, DO | |
|
1500 E Sherman Blvd, Floor 4, Muskegon, MI 49444-1884 | |
| (231) 672-6600 | |
| (231) 672-4695 |
| Full Name | Dr Shanon M Tuter-spitzley |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 1500 E Sherman Blvd, Muskegon, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891008074 | NPI | - | NPPES |
| 1891008074 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5101019523 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
News Archive
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.
The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.
Children who are bullied in primary and secondary school are nearly twice as likely to be overweight at the age of 18 than non-bullied children, according to a new study by researchers from King's College London.
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
› Verified 9 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.
The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.
Children who are bullied in primary and secondary school are nearly twice as likely to be overweight at the age of 18 than non-bullied children, according to a new study by researchers from King's College London.
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
› Verified 9 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972771657 PECOS PAC ID: 7416865845 Enrollment ID: O20031218000354 |
News Archive
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.
The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.
Children who are bullied in primary and secondary school are nearly twice as likely to be overweight at the age of 18 than non-bullied children, according to a new study by researchers from King's College London.
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shanon M Tuter-spitzley, DO Po Box 776982, Chicago, IL 60677-6982 Ph: (800) 494-5797 | Dr Shanon M Tuter-spitzley, DO 1500 E Sherman Blvd, Floor 4, Muskegon, MI 49444-1884 Ph: (231) 672-6600 |
News Archive
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.
The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.
Children who are bullied in primary and secondary school are nearly twice as likely to be overweight at the age of 18 than non-bullied children, according to a new study by researchers from King's College London.
AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.
› Verified 9 days ago
Dr. Mark T Karnes, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1775 Wells Ave, Muskegon, MI 49442 Phone: 231-773-9048 Fax: 231-777-1218 | |
Dr. Suzanne Marie Galloway, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 201a, Muskegon, MI 49442 Phone: 231-672-6600 Fax: 231-728-1719 | |
Katherine Mccormick, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 428, Muskegon, MI 49442 Phone: 231-672-3300 Fax: 231-672-3380 | |
Katherine E Betcher, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 201a, Muskegon, MI 49442 Phone: 231-672-6600 Fax: 231-728-4691 | |
Karissa Leah Tryska, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St, Suite 428, Muskegon, MI 49442 Phone: 231-672-3300 Fax: 231-672-3380 | |
Dr. Thomas Edward Mccurdy, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2201 S Getty St, Muskegon, MI 49444 Phone: 231-737-1802 Fax: 231-737-1808 | |
Dr. Michael L Baker, D.O Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2005 Addison St, Muskegon, MI 49441 Phone: 231-288-6383 |